Cipher Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Cipher Pharmaceuticals Inc. is publicly traded on TSX under the ticker CPH.TO.
Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada, operates as a specialized pharmaceutical enterprise. The company markets a diverse portfolio of commercial therapeutic solutions. These include Epuris (CIP-ISOTRETINOIN), formulated for severe acne; Ozenoxacin, targeting impetigo in both adult and pediatric patients; Actikerall, prescribed for palpable or moderately thick hyperkeratotic...
Can you invest in Cipher Pharmaceuticals Inc.?
Yes. Cipher Pharmaceuticals Inc. is publicly traded on TSX under the ticker CPH.TO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cipher Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.